GLP-1 Medications for PCOS: How They Help with Insulin Resistance
Medically reviewed by Puja Vyas, Lead Clinical Pharmacist.
PCOS brings real challenges - not just physical, but emotional too. For many women it means irregular periods, unwanted hair growth, and weight that's hard to shift. Those symptoms can wear down your confidence and affect daily life.
We now understand that much of this traces back to one root issue: insulin resistance. It sits at the heart of the hormonal imbalance in PCOS, and it's why a class of medications first designed for type 2 diabetes - GLP-1 receptor agonists - is showing real promise.
This guide covers how GLP-1 medications work, what sets them apart, and why they may help women manage PCOS.
What Is PCOS?
PCOS is one of the most common hormonal conditions in women, affecting 6–20% of women of reproductive age.
The main symptoms are:
- Irregular or absent periods
- Excess hair growth (hirsutism)
- Weight gain that's hard to reverse
- Acne and skin changes
These symptoms often feed into each other, which is what makes PCOS feel so hard to manage.
What Insulin Does in the Body
To understand PCOS, it helps to know what insulin is meant to do. Made by the pancreas, it's released after you eat to keep blood sugar stable. It has three main jobs:
- Fuels your cells: It moves glucose out of your blood and into cells for energy.
- Stores energy: It banks spare glucose as glycogen in the liver and muscles.
- Builds and repairs: It helps cells take up amino acids for muscle growth and repair.
When those processes run smoothly, blood sugar stays steady. In PCOS, they don't - and that's where the trouble starts.
The Link Between PCOS and Insulin Resistance
Insulin resistance is when your cells stop responding well to insulin.
It affects an estimated 50–70% of women with PCOS. Here's the chain reaction it sets off:
- Your cells respond poorly to insulin.
- Your pancreas makes more insulin to compensate (this is called hyperinsulinemia).
- High insulin levels tell your ovaries to make more androgens (male-type hormones).
- Those extra androgens drive the classic PCOS symptoms.
Left unchecked over time, this pattern can also raise your risk of type 2 diabetes.
How high insulin drives symptoms
- Irregular periods: High insulin disrupts ovulation and raises androgens, throwing off your cycle.
- Excess hair growth: More androgens lead to male-pattern hair growth.
- Weight gain: High insulin promotes fat storage and makes weight harder to lose - which then worsens insulin resistance. A vicious cycle.
Breaking that cycle is the key to easing symptoms — and it's exactly where GLP-1 medications come in.
How GLP-1 Medications Work
GLP-1 receptor agonists copy a natural gut hormone your body releases when you eat. They act in a few ways at once:
- Boost insulin when you need it: They prompt the pancreas to release insulin only when blood sugar is high.
- Lower glucagon: They reduce the hormone that raises blood sugar.
- Slow digestion: Food stays in your stomach longer, so you feel full for longer.
- Reduce appetite: You feel satisfied with less food.
- Support weight loss: A knock-on effect that further improves insulin sensitivity.
The Benefits for Women with PCOS
1. Better insulin sensitivity
This is the big one. GLP-1 medications improve how your body responds to insulin - and the research suggests they do it directly, not just through weight loss.
- One study found liraglutide improved insulin sensitivity within two weeks, before any real weight loss.
- A review found GLP-1 medications beat metformin at improving insulin sensitivity in women with PCOS.
Researchers think this works through several routes: increasing glucose transporters in insulin-sensitive tissues, lowering inflammation, and improving how the body handles fats. Because the effect isn't only about weight, these medications can help even before the scale moves.
2. Weight loss
GLP-1 medications reduce appetite and slow digestion, so you eat less without white-knuckling it.
The payoff for PCOS is significant. Losing just 5% of body weight has been shown to restore more regular ovulation and lower testosterone levels.
3. More regular periods and better fertility
By easing insulin resistance and supporting weight loss, GLP-1 medications can help restore ovulation.
- In one study, 62% of women on liraglutide reached a healthy bleeding pattern, versus 28% on placebo.
- In another, 42 overweight women with irregular ovulation took exenatide, metformin, or both for 24 weeks. All three groups ovulated more often - and the combination worked best.
Notably, the improvement in cycles tracked closely with weight loss, so shedding excess weight appears to do much of the heavy lifting alongside the medication's direct effects.
Early research also points to benefits for the womb lining itself: GLP-1 medications may reduce oxidative stress and scarring in the endometrium, both linked to implantation problems. Much of this is still preliminary or from animal studies, so it should be read as promising rather than proven.
(See the fertility caution in the FAQ - these medications are not recommended while trying to conceive.)
4. Lower androgen levels
Because high insulin drives androgen production, improving insulin sensitivity helps bring androgens down.
Research shows GLP-1 medications can lower circulating testosterone - and one meta-analysis found they were more effective than metformin at reducing androgens.
They may also help lower luteinising hormone (LH), which is often raised in PCOS and adds to androgen production. Lower androgens mean less hair growth, clearer skin, and more regular cycles.
Side Effects to Be Aware Of
Most side effects are mild and tend to ease as your body adjusts.
Common:
- Digestive symptoms — nausea, vomiting, diarrhoea, constipation. Most common when starting or increasing a dose. Around 30% of people feel some nausea early on. Smaller meals, avoiding strong smells, and staying hydrated all help.
- Injection-site reactions — mild redness or itching. Rarely a reason to stop.
- Headaches and cold-like symptoms — less common than digestive effects.
Also worth knowing:
- "Ozempic face" — facial fat loss from rapid weight loss can leave skin looking looser. It's more noticeable when weight comes off fast.
While these effects are usually manageable, they can affect how easily you stick with treatment — which is another reason clinical support matters.
Talk to a Clinician First
GLP-1 medications aren't right for everyone. Before starting, a clinician should review:
- Your health history — a history of pancreatitis or certain thyroid cancers may rule them out.
- Your other medications — to avoid interactions.
- Ongoing monitoring — regular check-ins to track results and catch side effects early.
The Bottom Line
GLP-1 receptor agonists are a promising option for managing PCOS - especially the insulin resistance at its core. By improving insulin sensitivity, supporting weight loss, and helping balance hormones, they can ease many of the symptoms that make PCOS so hard to live with.
They aren't a cure, and they aren't officially approved for PCOS. But for many women, they offer something that's been in short supply: a realistic path toward feeling better.
- PCOS and weight loss: why it's harder and what actually helps →
- PCOS and hair loss: causes and treatment options →
- PCOS (PMOS): Symptoms, Causes and Treatment Explained →
- Mounjaro and PCOS: what the evidence says →
- PCOS Diagnosis: Blood Tests, Criteria and How to Know If You Have It→
- GLP-1 Medications for PCOS: How They Help with Insulin Resistance →
- PCOS Diet: What to Eat, What to Limit, and What Actually Helps →
FAQs
How do GLP-1 medications help with PCOS?
They improve insulin sensitivity, support weight loss, and help regulate blood sugar. Since insulin resistance is so common in PCOS, lowering insulin levels can help with both weight and hormonal balance. Note: using GLP-1 medications for PCOS is off-label -it isn't an MHRA- or NICE-approved use, so speak to your healthcare provider.
Can I use them if I'm trying to get pregnant?
Not recommended. Their effects on fertility are still being studied, and NICE advises against use in the pre-conception phase. Always consult your provider first.
Are they safe for long-term use?
They're considered generally safe long-term for diabetes and obesity, with promising signs for PCOS. As it's a newer use, these medicines remain under monitoring. The inverted black triangle (▼) symbol marks medicines under intensive safety surveillance by the Medicines and Healthcare products Regulatory Agency (MHRA). This classification applies to new medications, or new indications, where there's less long-term real-world data compared with older drugs.
What are the main side effects?
Most often nausea, vomiting, and diarrhoea, especially early on. These usually settle as your body adjusts. See a provider if they're severe or persistent.
Do they help with PCOS symptoms beyond weight and insulin?
Possibly. There's evidence they may lower androgens, which drive hair growth and acne. More research is needed, but some women report improvements. Discuss your full symptom picture with your provider.
References
- Dunaif A, Segal KR. Insulin Resistance and the Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 1997.
- Patel S, Mehta S. GLP-1 receptor agonists in the treatment of insulin resistance and obesity in polycystic ovary syndrome. Journal of Endocrinology and Metabolism. 2022.
- Mashayekhi M, et al. Liraglutide results in increased insulin sensitivity independent of weight loss. Diabetes. 2024.
- Briant LJB, White S, Holst JJ. Weight loss–independent effect of liraglutide on insulin sensitivity in type 2 diabetes. Diabetes. 2024.
- Singh S, Prasad B, Jena G. GLP-1 receptor agonists in polycystic ovary syndrome: potential therapeutic role in managing metabolic dysfunctions. 2022.
- Zhang X, Li Y, Wang Y. The effects of GLP-1 receptor agonists on metabolic and reproductive outcomes in women with polycystic ovary syndrome. 2022.
- The Role of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Polycystic Ovary Syndrome: A Review. International Journal of Environmental Research and Public Health. 2022.
- Vrbikova J, Hainer V. Obesity and polycystic ovary syndrome. Obesity Facts. 2009;2(1):26–35.
- Tan S, Scherag A, Janssen OE, et al. Metabolic and cardiovascular impact of family history of type 2 diabetes in women with polycystic ovary syndrome. 2018.
- Buse JB, Wexler DJ, Tsapas A, et al. American Diabetes Association: Management of hyperglycemia in type 2 diabetes. 2010.
The content on the SheMed blog is provided for general informational and educational purposes only. While SheMed provides professional weight loss services and strives to ensure the information shared is accurate and up to date, we make no representations or guarantees as to its accuracy, completeness, or timeliness. This content should not be taken as personal medical advice or a substitute for consultation with a qualified healthcare provider. Always speak with your doctor or licensed medical professional about your individual health or medical needs before starting any new treatment or programme. Never disregard or delay seeking professional medical advice because of something you have read on this site. SheMed is not responsible for any actions you may take based on the information provided in this blog.
Related Articles
